For more 50 than years, the U.S. military has maintained a substantial program for infectious disease research in Kenya. These collaborations have expanded to eight countries under the U.S. Army Medical Research Directorate–Africa (USAMRD-A), which is headquartered on the campus of the Kenya Medical Research Institute (KEMRI) in Nairobi.
WRAIR helped establish the KEMRI-Kericho Clinical Research Centre (CRC) 1999 in collaboration with KEMRI and HJF, and a new CRC opened in 2012 where more than 50 clinical studies have been completed. The Kericho CRC has conducted randomized, double-blind, placebo-controlled and IND/FDA-regulated studies from Phase I to IV.
- Vaccines against HIV, Ebola and polio; therapeutics against HIV, diarrhea, tuberculosis and opportunistic diseases/ malignancies
- Chosen by several Shigella vaccine manufacturers to conduct three large scale multivalent Shigella vaccine trials
- NIH Networks – Part of National Institutes of Health Division of AIDS/AIDS Clinical Trials Group (ACTG) and IMPAACT, the maternal/child HIV treatment and prevention research network funded by the National Institute of Child Health and Human Development